Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue, net
Operating expenses:    
Research and development 506,375 467,564
General and administrative 830,909 447,576
Total operating expenses 1,337,284 915,140
Loss from operations (1,337,284) (915,140)
Other income (expense)    
Interest income (expense) (245,437) 452
FMV adjustment for Contingent Stock and Warrants (287,000)  
Total Other Income (Expense) (532,437) 452
Net loss and comprehensive loss $ (1,869,721) $ (914,688)
Net loss per share, basic and diluted $ (0.36) $ (0.20)
Weighted average shares used to compute net loss per share, basic and diluted 5,187,062 4,597,000